Literature DB >> 27609841

Imaging Tumor Metabolism to Assess Disease Progression and Treatment Response.

Kerstin N Timm1,2, Brett W C Kennedy1,2, Kevin M Brindle3,2.   

Abstract

Changes in tumor metabolism may accompany disease progression and can occur following treatment, often before there are changes in tumor size. We focus here on imaging methods that can be used to image various aspects of tumor metabolism, with an emphasis on methods that can be used for tumor grading, assessing disease progression, and monitoring treatment response. Clin Cancer Res; 22(21); 5196-203. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh：

Year:  2016        PMID： 27609841      PMCID： PMC5321522          DOI： 10.1158/1078-0432.CCR-16-0159

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  74 in total

1.  Conventional imaging and multiparametric magnetic resonance (MRI, MRS, DWI, MRP) in the diagnosis of prostate cancer.

Authors:  V Panebianco; A Sciarra; A Marcantonio; V Forte; T Biondi; A Laghi; C Catalano
Journal:  Q J Nucl Med Mol Imaging       Date:  2012-08       Impact factor: 2.346

Review 2.  Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.

Authors:  Gary J Kelloff; John M Hoffman; Bruce Johnson; Howard I Scher; Barry A Siegel; Edward Y Cheng; Bruce D Cheson; Joyce O'shaughnessy; Kathryn Z Guyton; David A Mankoff; Lalitha Shankar; Steven M Larson; Caroline C Sigman; Richard L Schilsky; Daniel C Sullivan
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

Review 3.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

4.  In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma.

Authors:  Charlotte Lussey-Lepoutre; Alexandre Bellucci; Aurélie Morin; Alexandre Buffet; Laurence Amar; Maxime Janin; Chris Ottolenghi; Franck Zinzindohoué; Gwennhael Autret; Nelly Burnichon; Estelle Robidel; Benjamin Banting; Sébastien Fontaine; Charles-André Cuenod; Paule Benit; Pierre Rustin; Philippe Halimi; Laure Fournier; Anne-Paule Gimenez-Roqueplo; Judith Favier; Bertrand Tavitian
Journal:  Clin Cancer Res       Date:  2015-10-21       Impact factor: 12.531

5.  In vivo and in vitro liver cancer metabolism observed with hyperpolarized [5-(13)C]glutamine.

Authors:  C Cabella; M Karlsson; C Canapè; G Catanzaro; S Colombo Serra; L Miragoli; L Poggi; F Uggeri; L Venturi; P R Jensen; M H Lerche; F Tedoldi
Journal:  J Magn Reson       Date:  2013-04-26       Impact factor: 2.229

6.  Simultaneous Hyperpolarized 13C-Pyruvate MRI and 18F-FDG PET (HyperPET) in 10 Dogs with Cancer.

Authors:  Henrik Gutte; Adam E Hansen; Majbrit M E Larsen; Sofie Rahbek; Sarah T Henriksen; Helle H Johannesen; Jan Ardenkjaer-Larsen; Annemarie T Kristensen; Liselotte Højgaard; Andreas Kjær
Journal:  J Nucl Med       Date:  2015-09-03       Impact factor: 10.057

7.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy.

Authors:  Sam E Day; Mikko I Kettunen; Ferdia A Gallagher; De-En Hu; Mathilde Lerche; Jan Wolber; Klaes Golman; Jan Henrik Ardenkjaer-Larsen; Kevin M Brindle
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

8.  Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast.

Authors:  Donna R Roberts; Kenton R Holden
Journal:  Brain Dev       Date:  2015-09-04       Impact factor: 1.961

Review 9.  Imaging tumor metabolism using positron emission tomography.

Authors:  David Y Lewis; Dmitry Soloviev; Kevin M Brindle
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

10.  Hyperpolarized [1-13C]-ascorbic and dehydroascorbic acid: vitamin C as a probe for imaging redox status in vivo.

Authors:  Sarah E Bohndiek; Mikko I Kettunen; De-en Hu; Brett W C Kennedy; Joan Boren; Ferdia A Gallagher; Kevin M Brindle
Journal:  J Am Chem Soc       Date:  2011-07-08       Impact factor: 15.419
View more
  5 in total

1.  Metabolism of hyperpolarized 13 C-acetoacetate to β-hydroxybutyrate detects real-time mitochondrial redox state and dysfunction in heart tissue.

Authors:  Wei Chen; Gaurav Sharma; Weina Jiang; Nesmine R Maptue; Craig R Malloy; A Dean Sherry; Chalermchai Khemtong
Journal:  NMR Biomed       Date:  2019-04-10       Impact factor: 4.044

Review 2.  Dynamic nuclear polarisation: The future of imaging in oncology?

Authors:  Eva M Serrao; Kevin M Brindle
Journal:  Porto Biomed J       Date:  2017-02-10

3.  Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection.

Authors:  Puneet Bagga; Mohammad Haris; Kevin D'Aquilla; Neil E Wilson; Francesco M Marincola; Mitchell D Schnall; Hari Hariharan; Ravinder Reddy
Journal:  J Transl Med       Date:  2017-05-30       Impact factor: 5.531

Review 4.  Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology.

Authors:  John Kurhanewicz; Daniel B Vigneron; Jan Henrik Ardenkjaer-Larsen; James A Bankson; Kevin Brindle; Charles H Cunningham; Ferdia A Gallagher; Kayvan R Keshari; Andreas Kjaer; Christoffer Laustsen; David A Mankoff; Matthew E Merritt; Sarah J Nelson; John M Pauly; Philips Lee; Sabrina Ronen; Damian J Tyler; Sunder S Rajan; Daniel M Spielman; Lawrence Wald; Xiaoliang Zhang; Craig R Malloy; Rahim Rizi
Journal:  Neoplasia       Date:  2018-11-23       Impact factor: 5.715

5.  Early Detection of Pancreatic Intraepithelial Neoplasias (PanINs) in Transgenic Mouse Model by Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy.

Authors:  Prasanta Dutta; Susana Castro Pando; Marilina Mascaro; Erick Riquelme; Michelle Zoltan; Niki M Zacharias; Seth T Gammon; David Piwnica-Worms; Mark D Pagel; Subrata Sen; Anirban Maitra; Shayan Shams; Florencia McAllister; Pratip K Bhattacharya
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 6.208
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.